Fuji Pharma Co.,Ltd.
富士製薬工業株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4554
FY2024 · 2025-09-30
| Gross margin | 40.2% |
| Operating margin | 9.7% |
| Net margin | 5.8% |
| Return on equity | 6.8% |
| Return on assets | 3.2% |
| Revenue growth (YoY) | 12.0% |
| EPS (basic) | ¥122.94 |
| EPS growth (YoY) | -51.4% |
| Current ratio | 1.55x |
| Equity ratio | 47.3% |
| Book value / share | ¥1,917.82 |
| Free cash flow | 3,820 M |